60 Gracechurch Street
6th Floor
London EC3V 0HR
United Kingdom
https://www.cizzlebiotechnology.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 4
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
El ISS Governance QualityScore de Cizzle Biotechnology Holdings Plc, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.